SCHEMBL7284669

SCHEMBL7284669

CC1(C)CNCC(C)(C)C1Cc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
GBA1 P04062 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1558534 0.69 GBA1 (0.48) GBA1
SCHEMBL33373857 0.69 POLB (0.42) GBA1
Hydrochloric Acid SCHEMBL483179 0.67 MAOA (0.37) GBA1
SCHEMBL9852828 0.67 CA2 (0.42) GBA1
SCHEMBL23477826 0.67 POLB (0.42) GBA1
SCHEMBL28450441 0.67 POLB (0.42) GBA1
SCHEMBL16707824 0.67 SLC6A2 (0.40)
SCHEMBL25408856 0.67 GBA1 (0.59) GBA1
SCHEMBL7284664 0.67 CALM1 (0.42)
SCHEMBL6979673 0.66 GBA1 (0.37) GBA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5254682-A Treating hypertension, hyperaldosteronism, congestive heart failure; glaucoma MERCK & CO., INC. (US) 1993-10-19 US disclosed
EP-0518675-A2 Cyclic renin inhibitors MERCK & CO. INC. (US) 1992-12-16 EP disclosed
EP-0518672-A2 Cyclic renin inhibitors MERCK & CO. INC. (US) 1992-12-16 EP disclosed
EP-0432974-A1 Cyclic renin inhibitors MERCK & CO. INC. (US) 1991-06-19 EP disclosed
EP-0431972-A2 Macrocyclic lactones having renin inhibiting properties MERCK & CO. INC. (US) 1991-06-12 EP disclosed